Ling Zhou

784 total citations
46 papers, 561 citations indexed

About

Ling Zhou is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ling Zhou has authored 46 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ling Zhou's work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Ling Zhou is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related gene regulation (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Ling Zhou collaborates with scholars based in China, United States and Hong Kong. Ling Zhou's co-authors include Min Zhong, Qiuju Xiong, Chenglong Wu, Yuke Tian, Xiaojun Xiang, Ziling Fang, Zhi Fang, Jian‐Ping Zou, Jianping Xiong and Yi Le and has published in prestigious journals such as Circulation, Oncogene and Frontiers in Immunology.

In The Last Decade

Ling Zhou

42 papers receiving 556 citations

Peers

Ling Zhou
Ling Zhou
Citations per year, relative to Ling Zhou Ling Zhou (= 1×) peers Xuemei Sun

Countries citing papers authored by Ling Zhou

Since Specialization
Citations

This map shows the geographic impact of Ling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhou more than expected).

Fields of papers citing papers by Ling Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhou. The network helps show where Ling Zhou may publish in the future.

Co-authorship network of co-authors of Ling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Zhou. A scholar is included among the top collaborators of Ling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Zhou. Ling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Yi, Ling Zhou, Yan He, et al.. (2025). SNX5 facilitates the progression of gastric cancer by increasing the membrane localization of LRP5. Oncogene. 44(17). 1182–1196. 1 indexed citations
2.
Zhang, Hongjiao, Juanjuan Zhou, Liping Liu, et al.. (2025). Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments. Carcinogenesis. 46(2). 1 indexed citations
3.
Li, Xiaodan, Xiaowei Li, Ling Zhou, et al.. (2025). Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges. Current Oncology Reports. 27(3). 195–210. 2 indexed citations
4.
Yang, Xiao, Chengcheng Li, Yuan Cheng, et al.. (2025). YY1-glycolytic axis promotes high glucose-induced cancer stemness in endometrial cancer: A multi-omics guided therapeutic strategy. Cancer Letters. 632. 217936–217936.
5.
Yu, Kun, H. Liang, Ke Li, et al.. (2024). Regulatory effect of rapamycin on recruitment and function of myeloid-derived suppressor cells in heart failure. International Immunopharmacology. 141. 112965–112965. 2 indexed citations
6.
Liu, Yawen, Juanjuan Zhou, Weiqi Liu, et al.. (2024). The E3 ubiquitin ligase RNF6 facilitates the progression of cervical cancer by inhibiting the Hippo/Yap pathway. Cell Division. 19(1). 32–32. 3 indexed citations
7.
Zhong, Min, Ling Zhou, Yun-Zheng Le, et al.. (2024). SPIN1 accelerates tumorigenesis and confers radioresistance in non-small cell lung cancer by orchestrating the FOXO3a/FOXM1 axis. Cell Death and Disease. 15(11). 832–832. 1 indexed citations
8.
Zhou, Ling, Hui Guo, Quan Liao, et al.. (2023). miR‐3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi‐targets. Journal of Cellular and Molecular Medicine. 27(20). 3090–3106. 4 indexed citations
9.
Zou, Jian‐Ping, Ling Zhou, Yi Le, et al.. (2023). WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein. Cell Communication and Signaling. 21(1). 38–38. 19 indexed citations
10.
Zhou, Ling, Hongjiao Zhang, Juanjuan Zhou, et al.. (2023). A comprehensive analysis of the expression, immune infiltration, prognosis and partial experimental validation of CHST family genes in gastric cancer. Translational Oncology. 40. 101843–101843. 2 indexed citations
11.
Zhou, Ling, Heng Wang, Min Zhong, et al.. (2022). The E3 Ubiquitin Ligase TRIM11 Facilitates Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway via Destabilizing Axin1 Protein. Journal of Oncology. 2022. 1–14. 14 indexed citations
13.
Liu, Wei, Ling Zhou, Xiaofeng Wu, et al.. (2022). Development and Validation of a Prognostic Nomogram in Lung Cancer With Obstructive Sleep Apnea Syndrome. Frontiers in Medicine. 9. 810907–810907. 7 indexed citations
14.
Zhou, Ling, Heng Wang, Zhi Fang, et al.. (2021). The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway. Bioengineered. 12(2). 12036–12048. 12 indexed citations
15.
Wang, Yao, Ling Zhou, Jie Yin, et al.. (2021). Increased let-7b-5p is associated with enhanced BAFF-R expression and B cell survival in immune thrombocytopenia. International Immunopharmacology. 93. 107393–107393. 9 indexed citations
16.
Zhong, Min, Ling Zhou, Zhi Fang, et al.. (2021). Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway. World Journal of Gastroenterology. 27(26). 4221–4235. 26 indexed citations
17.
Li, Shiyong, et al.. (2015). Effect of Propofol on the Expression of MMP-9 and Its Relevant Inflammatory Factors in Brain of Rat with Intracerebral Hemorrhage. Cell Biochemistry and Biophysics. 72(3). 675–679. 9 indexed citations
18.
Xu, Maolei, Ling Zhou, Peng Zhang, et al.. (2013). Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine. Tumor Biology. 34(5). 3173–3182. 8 indexed citations
19.
Zhou, Ling. (2008). Relationships between Environmental Factors and Combined Allergic Rhinitis and Asthma Syndrome and Asthma in Children. Testowy IndexCopernicus. 1 indexed citations
20.
Zhou, Ling, et al.. (1990). Factors associated with the decline of the Cooperative Medical System and barefoot doctors in rural China. Health Policy. 14(2). 151–151. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026